4.5 Article

Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Molecular therapy in head and neck oncology

Jacques Bernier et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2009)

Article Oncology

SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation

Kyle C. Cuneo et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

Review Medicine, Research & Experimental

New molecularly targeted therapies for lung cancer

Sophie Sun et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Review Oncology

Radiation-induced cell signaling: inside-out and outside-in

Kristoffer Valerie et al.

MOLECULAR CANCER THERAPEUTICS (2007)

Review Multidisciplinary Sciences

Ras, PI(3)K and mTOR signalling controls tumour cell growth

Reuben J. Shaw et al.

NATURE (2006)

Article Pharmacology & Pharmacy

Sunitinib malate for the treatment of solid tumours: a review of current clinical data

Robert J. Motzer et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)

Review Medicine, General & Internal

External beam radiotherapy as curative treatment of prostate cancer

TM Pisansky

MAYO CLINIC PROCEEDINGS (2005)